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Thesis Summary
Peripheral Arterial Disease is a growing epidemic throughout the United
States. It is estimated that 8 to 12 million Americans currently suffer from PAD, a
disease of the circulatory system that limits blood flow to your hands and feet.
This limited blood flow is due to the narrowing of the arteries that supply blood
throughout your body and can disrupt the balance of the nerves and tissues that
make up your extremities. If left untreated, it can cause irreparable, lifethreatening damage that may result in amputation of the diseased limb. Although
the mechanism of PAD is known and well understood, different treatment options
are still being researched and evaluated in order to fully understand which is the
most effective and efficient for each clinical presentation.
The least invasive treatment options are lifestyle changes, including the
implementation of exercise regimes or medical therapy in an effort to control the
primary causes of PAD. However, these may be met with limited success, and
greater more invasive intervention may be necessary. Surgical treatment options
usually include the use of a long wire to reach the obstructed region of the blood
vessel and remove the plaque. In rare cases, it may be necessary to use a manmade artery in order to create an alternate route for blood to flow around the
occluded segment. All of these surgical interventions require the use of an
imaging technique in order to both navigate through the arteries to the obstructed
segment and view the plaque accumulation inside the vessel.
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Angiography has long been considered to be the best method for
navigating through the different arteries of the leg, even though its ability to view
the accumulated plaque is adequate at best. In recent years, intravascular
ultrasound has shown to be capable of providing more accurate details regarding
the vessel lumen, plaque shape, and composition as compared to angiography.
A greater understanding of these components aids in both the diagnostic and
treatment process. Intervening physicians are able to gain a greater
understanding of where the obstruction is located and how bad it is, which allows
them to better decide if intervention is necessary. In addition, in the event that
intervention is warranted, greater knowledge regarding the plaque shape and
composition allows them to choose the interventional technique that will produce
the best outcome for the patient.
The solution to the current lack of information most likely comes in the
form of using IVUS in adjunct with angiography during interventional procedures.
This would allow the intervening physician to both navigate to the right location
and view the extent of the plaque accumulation. IVUS, however, is currently
limited by its cost of implementation, which can range anywhere from $70,000$120,000 for a basic system, in addition to a $600 disposable catheter tip per
patient. As research continues to develop, new solutions and technological
advancements may help lower the costs of the existing technology.
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Introduction
Peripheral arterial disease (PAD) is a disease of the circulatory system
classified by the narrowing and hardening of the arterial wall due to the buildup of
fatty deposits called plaque. PAD affects at least 8 to 12 million Americans, and
one in every three people 70-years of age or older has PAD.1 As plaque fills the
arterial wall, blood flow distal to the obstructed region is reduced. If the blood
volume provided to the distal vasculature is not sufficient to keep up with the
tissue’s oxygen demands, damage to the nerves or tissue may occur. There are
many risk factors – conditions that increase the risk of disease or infection –
associated with PAD, including: smoking, old age, diabetes, hyperlipidemia,
hypertension, and renal insufficiencies. These risk factors may also lead to other
co-morbidities such as Coronary Artery Disease and heart attacks or strokes. If
left untreated, PAD can progress into a Critical Limb Ischemia, a more serious
form of PAD that can result in chronic pain and/or numbness in the feet or toes,
nonhealing wounds or ulcers, tissue necrosis (gangrene), and even amputation
of the affected limb. PAD is also likely to be a sign of widespread accumulation of
fatty deposits within the arteries of other areas of your body.
When diagnosing patients suspected of PAD, physicians utilize a sliding
scale of diagnostic tests ranging from least invasive to most invasive. Although
each patient’s presentation will ultimately determine his or her treatment, the
general procedure is as follows. After collecting their medical and family history,
the physician usually conducts a physical exam that checks blood flow for weak
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or absent pulses and compares blood pressure between the left and right side of
the circulatory system (measured at the brachial artery of each arm). Then,
further non-invasive testing is conducted in order to determine the general
progression of atherosclerosis. The Ankle-Brachial Index compares blood
pressure in your ankle to blood pressure in your arms, with a normal reading
ranging from 0.9 to 0.13. The Segmental Leg Pressures test leg pressures at the
ankle, blow the knee, above the knee, mid-thigh, wrist, below the elbow, above
the elbow, and mid upper arm. By identifying the location with the greatest drop
in blood pressure, it is possible to narrow down the location of the possible
arterial occlusion to a certain segment.
Treatment
Treatment begins with lifestyle changes that minimize the risk factors for
PAD, such as the implementation of exercise regimes or smoking cessation. In
addition, medical therapy and pharmaceutical options may be undertaken in an
effort to lower cholesterol, prevent blood clots, or minimize pain. Surgical
treatments are only considered if the previously mentioned treatment options fail.
Angioplasty and stenting procedures utilize a system of guide wires and
catheters with a balloon at the tip. The tip is inserted into the artery and inflated,
pushing the plaque outward into the arterial wall. A small mesh tube is then
placed in the artery to help maintain the patency of the vessel. Atherectomy is a
similar procedure in which the balloon tip of the catheter is replaced by a small
cutting device that is inserted into the artery and used to remove the plaque
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burden. Finally, the most invasive option, a bypass graft, uses a blood vessel
from another part of the body or a man-made tube to bypass the occluded arterial
segment. Amputation of the diseased leg is reserved as a last resort in the event
that the patient’s life is in danger. Treatment decisions are ultimately dependent
upon the characteristics of the stenosis as well as the symptoms and comorbidities of the patient.
Imaging Modalities
Vascular surgeons, cardiologists, and radiologists alike rely heavily on
imaging modalities for both diagnostic and procedural assistance when treating
patients with PAD. Angiography has long been considered the “gold standard” for
investigating the vessel lumen, defining peripheral vasculature, and providing
arterial navigation during percutaneous procedures.2 Typically, cardiologists use
a system of guide wires and catheters to inject a contrasting agent into the
femoral artery. They can then use X-ray imaging to view the dye, which shows up
by absorbing the X-rays, as it passes through the blood vessel of interest.
Angiography is capable of depicting characteristics of both the lumen and lumenborder interface, allowing for evaluation of atherosclerotic plaque burden and
morphology.3 Image accuracy is limited by arterial wall motion artifact, vessel
tortuosity, overlying structures, or overlapping vessels, which may reduce
accurate interpretation regarding the extent of the plaque burden, although this
can be overcome to some degree with multiplanar imaging. 3,4 To produce
multiplanar images, the arm of the X-ray machine is rotated to provide different
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visual planes of the arterial lumen. Angiography depicts the contour of the lumen,
but cannot quantitatively evaluate the level of atherosclerotic plaque buildup,
often resulting in misleading interpretations of stenosis.5,6 In addition, luminal
stenosis from angiography may not be in agreement with more accurate
quantitative measurements by intravascular ultrasound or histological analysis.6
These discrepant results may make the need for endovascular intervention
difficult to determine.
When treating patients suffering from PAD, the inability to objectively
evaluate plaque burden, composition, morphology, and vessel wall architecture
through angiography has led to underestimated arterial dimensions and degrees
of stenoses, which further limits thorough evaluation of the various interventional
options, let alone whether or not intervention is necessary.3,7 As a result,
angiography may contribute to reduced long-term procedural success rates
during endovascular interventions as compared to IVUS, resulting in increased
rates of restenosis, thrombosis, and other post-procedural complications.
Although the intervening physicians are dependent on angiography for arterial
navigation, intravascular ultrasound (IVUS) has shown potential to assist in both
diagnostic and interventional procedures by providing intraluminal cross-sectional
images with higher image resolution than angiography.
Similar to angiography, IVUS utilizes a system of guide wires and
catheters in order to collect information; however, IVUS deploys a miniature
ultrasound device on the distal end of the catheter that allows the operator to see
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through the surrounding blood column and visualize the inner wall of blood
vessels from inside the vessel itself. Percutaneous IVUS catheters capture crosssectional images that enable 360°-intraluminal visualization of peripheral
vasculature. A revolving transducer on the catheter tip emits ultrasound waves
during pullback of the probe through the vessel segment of interest. The axial
scan uses a grey scale to differentiate amplitudes of reflecting ultrasound waves
from different tissue types, enabling the categorization of different plaque types
according to their composition. Calcified plaque reflects brightly because it
impedes ultrasound waves, appearing white, while thrombus is much more
hypoechoic and reflects dark grey.8 The close proximity of the probe allows for a
higher frequency ultrasound to be used, which in turn provides higher image
resolution and magnification compared to other imaging techniques. This enables
more accurate assessment of vessel or lesion diameters and lengths, plaque
shape, length, volume, composition, and concentricity, as well as the
completeness of treatment after intervention.9 IVUS is also capable of stacking
consecutive images in order to create a 3-D image of the plaque. These detailed
images and cross-sectional measurements, when used in adjunct with
angiography, can increase the capability and accuracy of diagnostic and
interventional procedures for patients with PAD. Each image has the potential to
uncover critical information that can be utilized to increase technical success and
long-term outcomes.
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Stenosis
Angiography details the continuity of the peripheral vasculature through
representation of the vessel lumen.5 Evidence of stenoses can be measured
through decreases in the luminal area; theoretically, as plaque begins to
accumulate along the vessel wall the cross-sectional area should decrease and
limit distal blood flow. However, histological analysis has shown that the elasticity
of the external elastic membrane (EEM) allows the arterial walls to expand
centrifugally in order to accommodate the accumulating plaque.6 Because of this
positive remodeling of the EEM, the lumen area may remain unchanged until
40% of the cross-sectional area is filled with atheroma deposits.6 Only after full
expansion of the arterial wall does further atheroma deposits begin to encroach
into the lumen. Even with multiple projections, angiographic evidence of stenoses
to support intervention is usually undetectable until the plaque covers 40-50% of
the total cross-sectional area of the artery.7
Kashyap et al. researched the effects of positive remodeling in minimally
diseased arteries with apparent stenosis <30%. Both linear and area stenosis
levels of popliteal artery segments were evaluated using angiography and
histological analysis of the internal elastic lamina (IEL). They determined that
their angiographic scoring of atherosclerotic burden (18.5%) consistently
underestimated the level of atherosclerosis when compared with the histological
findings (34.9%). Because angiography uses luminal diameter measurements to
calculate geometric dimensions, both IEL and vessel area stenosis
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measurements produced increasingly discrepant results compared to
angiography, 39.2 (p<0.0001) and 60.9 (p<0.0001) respectively.3
While angiography repeatedly underestimates stenoses when compared
with histological analysis, IVUS is capable of providing accurate luminal
dimensions to monitor plaque progression, in addition to offering additional
information on the arterial wall.3,10 IVUS correlates as high as 95% with
angiography when calculating luminal diameters, but is capable of determining
true vessel wall dimensions in both diseased and normal arteries. These more
accurate measurements account for positive remodeling and any plaque burden
not identified by angiography, increasing the accuracy when computing stenosis
area.11 Using true arterial dimensions to compute the maximal percent area
stenosis, IVUS determined a 10% degree of stenosis was unaccounted for by
angiography, most likely because luminal diameter measurements do not
account for positive remodeling.4
In addition to greater accuracy, IVUS is capable of surveying blood flow
within the lumen when using frequencies greater than 30MHz. This information
can replace subjective angiographic assessment of stenoses area with
quantitative measurements, enabling more accurate evaluation of stenoses while
still compensating for vascular remodeling.4,8 The discrepancy between actual
and inferred stenoses levels imposes severe limitations when evaluating the
need for endovascular intervention.
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Vessel Wall Morphology
Information on the interaction between plaque and the vessel wall is
essential when investigating peripheral atherosclerosis. The cross-sectional
diameter of the lumen is calculated with angiography by using the lumen
diameter dimensions. However, this method is best suited for concentric lesions,
as accuracy tends to decrease as the level of ellipticity increases.12 Angiography
is unable to provide this information accurately because of its limited ability when
defining dimensions of obstructed or irregular vessel segments. Angiography
overestimates the true lumen cross-sectional diameter compared with IVUS for
non-elliptical or irregular lumens because vessel wall architecture cannot be
accurately determined. This can result in an underestimation of lesion stenosis in
diagnostic studies or overestimation in the beneficial results of intervention.6
Analysis of the high-resolution images captured by IVUS may provide
insight into morphological characteristics of the vessel wall, plaque identification,
and location of lesions. This additional information can be used to analyze
mechanisms of plaque progression or recession and vessel-plaque interaction.13
In addition, the accurate measurements of maximum and minimum lumen
diameters enable calculation of the ellipticity index for each IVUS image. The
ellipticity index is the ratio of the maximum luminal diameter to the minimum
luminal diameter and defines the ellipticity for individual images.12 As the index
increases, the imaged lumen becomes more elliptic. Compared to angiography,
IVUS images and their morphological analysis produce more detailed information
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regarding the location, eccentricity, and cross-sectional area of the lumen.12
Accurate interrogation of vessel wall morphology may also be beneficial for
determining plaque characteristics, branch vessel location, and the extent of
disease involvement.14
Plaque Shape
Atherosclerotic plaque can accumulate in many different shapes and
lengths depending on spatial location and composition, but lesions are generally
classified as concentric or eccentric along with their fiber composition if it is
known. The shape in which atherosclerotic plaque accumulates is largely
determined by the curvature and elasticity of the inner arterial wall because
atherosclerotic plaque components tend to coagulate in areas of low shear
stress.2 Angiographic methods misrepresent plaque shape and volume because
of limitations for determining true arterial dimensions and compensating positive
or negative remodeling.7 While the operator can determine if stenosis is present,
detailed anatomical characteristics are unreliable even with multiple projections
of the diseased segment. On the other hand, the axial images IVUS produces
allows for evaluation of both lumen and true arterial diameters. By comparing the
true and luminal diameter measurements, it is possible to recreate the diseased
segment in order to accurately identify plaque architecture and volume.
Arthurs et al. documented the disassociation of plaque shape between the
two imaging modalities when they analyzed 93 patients with peripheral arterial
disease. Their angiographic data showed a shorter length of stenosis at 14.3mm,
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which underestimated the IVUS findings of 17.3mm by 3mm (20%).4 When
examining lesion concentricity, their IVUS results produced over twice as many
concentric lesions (60%) as compared to their angiographic results (28%),
showing that the angiographic operators were much more likely to overestimate
the ellipticity index for target lesions.4
In further evaluation of the findings from Arthurs et al., Kashyap et al.
compared concentricity data from angiographic and histological plaque
evaluations. Angiography underestimated plaque concentricity finding 23 of 59
(39%) plaque evaluations were concentric compared to 35 of 65 (54%)
concentric plaque evaluations from the histological analysis.3 Because most
atherosclerotic lesions are eccentrically located within the vessel, it would be
necessary to use multiplanar angiographic views to adequately evaluate the
degree of stenosis for a specific lesion.14 It is plausible to conclude that the
increased accuracy for computed measurements and the more accurate
concentricity findings are the result of the more accurate geometric data analysis
from IVUS over other imaging modalities when determining both true and
diseased diameters.
Plaque Morphology
When evaluating therapeutic options for PAD patients, plaque morphology
and target lesion information are helpful in predicting success rates of different
endovascular treatments. The information IVUS provides can help predict how
the target lesion will respond to therapeutic procedures and predict its interaction
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with blood flow and the vessel wall; these events will determine if the plaque will
resist recoil and balloon/stent deployment or be liable to embolization, dissection,
and/or perforation.15 Histological analysis can be used to analyze plaque
characteristics and determine composition, but this cannot be done in vivo
because the necessary tissue samples can only be obtained at autopsy.
Advancements in IVUS modalities, such as virtual histology IVUS (VH-IVUS) and
integrated backscatter IVUS (IB-IVUS) have facilitated the collection of the
necessary structural information in situ as well as the ability to assess plaque
morphology.13
Virtual Histology IVUS (VH-IVUS)
VH-IVUS is capable of providing valuable histological data for plaque by
analyzing the frequency and amplitude of backscattered radiofrequency (RF)
data and comparing the acquired information to RF spectral profiles based on the
echogenicity of different tissue types.2,13 The reflecting signals are combined
through a process known as synthetic aperture to recreate the image.13 When
recreating the image, VH-IVUS uses the RF spectral profiles to classifies lesions
in situ into color-coded categories based on four different histological
components of plaque: dark green: fibrous; yellow-green: fibro-fatty; white:
calcified; and red: necrotic lipid core.2,4,16
Although peripheral applications are still being researched, VH-IVUS in the
coronary has proved to be fairly accurate when compared with histological
analysis. Diethrich et al. compared thirty carotid plaque samples with their true
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histological results and recorded high correlations between the two histologies,
ranging from 72.4% (calcified fibroatheroma) to 99.4% (thin-cap fibroatheroma).
The results showed a strong correlation between VH-IVUS and histological
plaque characterization, especially in vulnerable plaque types, providing support
to the diagnostic accuracy of VH-IVUS.16 For comparison, IVUS correctly
identified calcium in 100% of the histopathology samples containing calcium,
while angiography identified only 54% and gray-scale IVUS missed one lesion.16
The accuracy levels for defining plaque morphology depicted instill confidence for
using VH-IVUS to track progression of atherosclerotic plaque volume and
changes to plaque composition.13
The ability to accurately analyze the morphology, spatial arrangement, and
geometric dimensions of vulnerable or calcified plaque types aides in the
evaluation of endovascular interventions and the selection of the appropriate
therapy. Other imaging methods are limited by reproducibility from the operator’s
ability to adjust intensity, frame average, and power level.13 Spectral analysis of
the pure RF backscatter data signals to determine lumen and vessel area as well
as plaque burden and composition has shown to have high correlation
coefficients (<0.90) and reproducibility rates similar to tradition IVUS
measurements.17 The reproducibility of VH-IVUS enables the quantitative
spectral measurements to act as a definitive standard when evaluating plaque
composition.13 The ability to accurately determine the different histological
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constituents of targeted plaque lesions in situ will be beneficial to facilitating
further understanding of different mechanisms related to PAD.
Plaque Calcification
Identifying plaque histology in situ is particularly helpful in identifying the
presence of calcified plaque. Calcified plaque is much harder compared to
fibrous plaque and can have many implications for patients with PAD, especially
regarding therapeutic options because of the decreased elasticity of the diseased
vessel segment. The specific shape, volume, and location of the calcified plaque
are essential factors when determining which interventional procedure is most
applicable, as more complex plaque and rapid plaque growth by area has been
associated with risk of stroke and heart attack. For example, during balloon
angioplasty, higher levels of plaque calcification will require increased balloon
inflation pressures compared to soft atherosclerotic plaque. The correct balloon
pressure is essential in order to prevent adverse effects or vessel disruption from
over-inflation. Contrarily, the softer, more fibrous lesions have greater elasticity
and may be treated with additional stenting and/or atherectomy to prevent
negative remodeling.10
Kashyap et al. quantified the limits of angiography in determining plaque
calcification by comparing angiographic evaluations to true histological results.
Angiographic evidence was used to differentiate plaque calcification into four
groups: none, minimal, moderate, and severe. Their results showed angiography
underestimated plaque calcification, with 15% of scores recording no calcification
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compared to 0% of histology. In addition, angiographic evidence identified 15% of
the samples as severe calcification, compared to 34% by histology.
Angiography’s inability to produce quantifiable plaque calcification data leads to
subjective interpretation, which appears to be the primary cause for the
discordant results. This conclusion was further supported by the relatively low
intraobserver reliability reported from the study (0.3985).3 These results not only
speak to the limits of angiography, but also to the need for a definitive standard
for quantifying calcified plaque in situ.
Calcified plaque can be identified through the bright white locations
depicted on IVUS images, providing interventionalists a better understanding of
lesion morphology, shape, and location. During atherectomy procedures, the
location of calcified plaque is directly related to the methodology used during
treatment. For example, high-speed rotational atherectomy is best suited for
superficial plaque close to the lumen surface. However, if the calcified plaque is
deep within the vessel wall in contact with the media, directional atherectomy
may be more appropriate.5 For these reasons, objective measurements on
specific plaque morphologies using IVUS are more valuable than the subjective
angiographic representation when selecting the appropriate therapy and
predicting results of the different interventions.
Technical Guidance
IVUS has a wide variety of clinical applications because of the numerous
data points that can be computed pre-, during, and post-therapeutic intervention.
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IVUS can provide assistance through accurate evaluation of the diseased and
true vessel dimensions, cross-sectional area, arterial wall architecture, lesion
dimensions, plaque morphology, concentricity, and virtual histology. From
conventional stenting to balloon angioplasty to atherectomy, IVUS imaging
results can be easily interpreted to provide essential information that adds realtime technical guidance to intravascular procedures.
IVUS’ ability to image entire vessel segments, including the lumen, wall,
and lesions, facilitates diagnosis and intervention in patients with PAD. True
arterial dimensions that include angiographically silent stenosis and vascular
remodeling can be compared to lumen measurements to determine lesion
morphology and the need for intervention. In diseased segments, IVUS obtains
reference data for specific vessel locations both proximal and distal to the target
lesion. These reference points define target areas for the interventional
procedure and allow for more accurate vessel and lesion analysis.2 Accurate
reference segments and vessel dimensions are equally beneficial for determining
correct device sizing so that all secondary plaque distal and proximal to the
stenosis will be treated. Many recent studies have recorded the positive effects of
IVUS on long-term clinical outcomes, some of which suggest that fewer postoperational complications reduce the need for re-intervention, potentially
offsetting the original invested procedural costs.5,10,14
Interventional cardiologists often use intravascular stents in adjunct with
balloon angioplasty to improve patient outcomes by compressing plaque outward
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against the inner arterial wall in order to maintain patency of the arterial lumen.14
Non-stented lesions treated with angioplasty alone have shown restenosis from
negative remodeling and elastic recoil of the treated vessel.11 Both immediate
and long-term patency of stented lesions appears to be directly related to proper
stent deployment, as determined by three factors: full stent expansion, complete
apposition to the vessel wall, and full lesion coverage during stent placement.10
Angiography provides luminal rather than true vessel measurements – that
include the plaque accumulation – when determining the appropriate stent size,
relying on subjective interpretation compared to the objective measurements of
IVUS.4 In addition to the precise measurements that enable more accurate stent
sizing, IVUS images showing the lesion and the stent-wall interface facilitate
more accurate stent positioning and expansion.9
Before stent deployment, IVUS can accurately assess the correct size to
which a vessel should be dilated. If the stent is not fully apposed to the vessel
wall, platelets, fibrin, and thrombus can accumulate between the stent and
arterial wall, forming a lesion that may serve as the starting point for restenosis.11
On the other hand, stent oversizing or overexpansion severely increases rates of
ischemic complications such as perforated or ruptured vessels.11 After device
implantation, IVUS can evaluate device placement, ensuring full device
expansion with complete stent-vessel wall apposition and no prolapsed plaque.10
The confirmation IVUS images provide may reduce complications - such as
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missing the lesion location, stent malapposition, or dislodged stents during
implantation – that are associated with in-stent restenosis.11
Arko et al. documented vessel diameters in 25 of 40 lesions (62%) were
underestimated when using angiography as compared to IVUS analysis. As a
result, 16 of 40 (40%) stented lesions were under-deployed by IVUS evaluation,
but appeared adequately expanded through angiography. They concluded
arteriography was of limited value for evaluating adequate stent expansion.10 In
further support, Clifford et al. documented 20 of 49 (41%) stents were determined
to be under-deployed by IVUS evaluation, even though angiography had depicted
adequate expansion.14
In addition to assisting in stenting and balloon angioplasty, true vessel
analysis has proven to be beneficial for atherectomy procedures. The ability to
quantify plaque volume in a vessel segment has enabled in-depth evaluation of
plaque removal techniques. Limitations on data analysis from angiographic
images allow for interpretation of changes in lumen space. As a result,
angiography has limited ability when attempting to differentiate between plaque
removal and vessel wall expansion because both mechanisms increase lumen
diameter. If vessel wall expansion were present, compensatory stretching would
increase lumen diameters, resulting in misleading angiographic evidence of
plaque removal. IVUS images offer definitive results due to the quantitative data
available from true vessel evaluation.6 IVUS may also offer further technical
guidance during atherectomy through proper blade orientation with respect to the
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target lesion, maximizing plaque removal while reducing inadequate debulking
and vessel perforation.5
Complications
Although angiography and other imaging modalities have facilitated
successful advancement of endovascular interventions, many procedures are still
plagued by immediate or long-term complications. During intervention, vessel
morphology is distorted making it difficult to analyze and quantify procedural
success from comparing post-operative results to pre-operative evaluations.6 In
addition, many interventional procedures are complex with multiple mechanisms
that can cause complications such as excess residual stenosis, restenosis, stent
malapposition, or stent thrombus. Accurate images are necessary to help reduce
the possibility of post-procedural complications and assess the completion of
treatment. IVUS analysis provides the information required to increase
interventional success rates and ensure thorough treatment.
Aside from malapposition or stent thrombus, other complications such as
restenoses or occlusions can result from the loss of arterial patency following
angioplasty or stenting. Residual stenosis data can quantify initial procedural
success and depict immediate changes in lumen area. Angiographic
interpretation following directional atherectomy has shown to underestimate
residual stenosis, identifying 21% residual plaque volume compared to the 48%
from IVUS evaluation.5
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Moderate to long-term procedural success is determined through
evaluation of the vessel lumen patency. Late obstructions to blood flow can result
from restenosis, occlusions, or stent failure. Clifford et al. researched the
influence of IVUS in addition to angiography compared with angiography alone
on the long-term patency of arterial lesions treated with balloon angioplasty and
primary stenting. After treating 49 limbs using IVUS and angiography, there were
no restenoses or occlusions recorded. The five-year patency rate was 100% and
no limbs needed additional treatment or evaluation because of suspected
restenoses or occlusions. However, after treating 22 limbs using angiography
alone, early restenosis or occlusion of stented lesions occurred in 4 limbs (18%).
The five-year patency rate was 82% and two cases of each severe stenoses and
occlusions were documented. In all four cases, subsequent IVUS evaluation
found under-deployed stents and additional intervention was needed. Including
two late failures from the angiography alone group, secondary procedures were
performed on 5 out of the 22 limbs evaluated (23%). They concluded IVUS
significantly improved long-term patency by correctly defining the optimal
angioplasty diameter endpoint and adequacy of stent deployment during the
initial procedure.14
A similar study by Frank et al. documented long-term patency data from
IVUS and angiographic analysis of 52 patients after balloon angioplasty and
stenting of atherosclerotic aortoiliac occlusive lesions. While none of the 36
IVUS-assisted patients had restenoses or occlusions, 4 of the 16 (25%) patients
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assisted by angiography alone developed restenoses or occlusions. All four were
found to have under-deployed stents and were subsequently treated with
adequate stent redeployment using IVUS criteria. These lesions remained patent
and continued to do so at the time the study was concluded four years later. In
the IVUS-assisted group, IVUS found 40% of the stents were under-deployed,
even though they appeared adequately expanded on angiography.10 They
concluded IVUS is possibly the best imaging method for assessing adequacy of
arterial stent deployment, which may then improve long-term clinical outcomes of
balloon angioplasty and stented aortoiliac occlusive lesions.11
Limitations
Even with all of the benefits IVUS has to offer during endovascular
interventions, there are some limitations to the technology, especially its
implementation. The biggest inhibitor of widespread integration of IVUS systems
is the associated costs of operation. Each disposable catheter-delivered
transducer costs approximately $500. The IVUS systems themselves can cost
between $70,000-$120,000 and require a trained technician to operate. On
average, the additional cost-per-case is approximately $1,000. However,
although there is a substantial upfront cost, investing in IVUS pays dividends
once the increased diagnostic abilities, technical guidance, and success rates are
factored in. Each failed endovascular procedure can costs around $12,000$15,000 to salvage. The increased success rate will allow catheterization labs to
recover their initial investment in lieu of the operational costs for reinterventions.14
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During the study performed by Clifford et al., if IVUS had salvaged the four
failures from the arteriography alone group during the initial treatment, the money
saved from not performing the four reconstructions would have paid for its use in
all 52 patients.14
Other limitations of IVUS are associated with its clinical applications or
analysis. Using a manual pullback system has the potential to cause inconsistent
retraction rates of the transducer, which could result in incorrectly stacked
images or poor image quality.8 IVUS also mandates additional time, equipment,
and personnel. In addition, there is no standard present between manufacturers,
so IVUS catheters cannot be interchanged.4 However, in experienced hands,
using an integrated IVUS system adds only a few minutes to procedural time.
The information is both information, necessary, and easy to interpret because of
the analysis software and color-coded maps of VH-IVUS.
Conclusion
Angiography is adequate for viewing luminal characteristics, but has
repeatedly been shown to provide inaccurate measurements without providing
insight into the vessel or plaque morphology. As geometric measurements
become more complex, evaluating stenosis areas, concentricity, and treatment
analysis with angiography has shown to produce increasingly discrepant results
when compared to IVUS. IVUS imaging and analysis software is capable of filling
the gaps with objective, quantifiable data that provides accurate analysis and
evaluation of the diseased and true lumen, lesions, and vessel walls. This is
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particularly true in significantly diseased vessels, in which IVUS can provide more
accurate evaluation of vessel wall and lumen morphology as well as plaque
distribution.12
In addition, IVUS has many clinical applications during interventional
procedures and has demonstrated positive effects on technical guidance,
treatment analysis, and long-term patency rates. With continuing advances in
therapeutic options, the success of interventional procedures may be directly
related to the capabilities of the accompanying guidance system. However, it is
important to note that angiography may still play a role in preliminary diagnosis
and peripheral navigation of the arterial vasculature. Ideally, IVUS should be
used in conjunction with angiography in order to incorporate the beneficial
aspects of both imaging modalities.
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